Cannabis-Based Treatment in Australia: Understanding Medical Cannabis and Patient Care

 

Healthcare continues to evolve as researchers explore different approaches to managing various medical conditions and improving patient wellbeing. One area receiving increasing attention is cannabis-based treatment in Australia. Medical cannabis has become an important topic of discussion among patients, healthcare professionals, and researchers interested in alternative and complementary treatment options.

Cannabis-based medicines contain compounds derived from the cannabis plant, including cannabidiol (CBD) and tetrahydrocannabinol (THC). These compounds interact with the body's endocannabinoid system, which plays a role in regulating several physiological processes.

In Australia, medicinal cannabis is subject to specific regulatory requirements and is generally accessed through an authorised medical practitioner. Understanding how cannabis-based treatment works, its potential applications, safety considerations, and access pathways can help patients make informed decisions with qualified healthcare professionals.

What Is Cannabis-Based Treatment?

Cannabis-based treatment refers to the medical use of products containing cannabinoids, which are naturally occurring chemical compounds found in the cannabis plant.

The two most widely discussed cannabinoids are:

•          Cannabidiol (CBD): CBD is a non-intoxicating cannabinoid. It does not produce the typical intoxicating effects associated with THC. It has been investigated for several potential therapeutic applications, although evidence and approved uses vary by product and condition.
•          Tetrahydrocannabinol (THC): THC is the principal psychoactive cannabinoid in cannabis. It can influence pain perception, appetite, nausea, and other physiological processes. However, it may also cause unwanted effects such as dizziness, impaired concentration, and changes in perception.

Medical cannabis products may contain CBD, THC, or a combination of both. Their composition, strength, formulation, and suitability depend on individual clinical circumstances.

Medical cannabis should not be confused with recreational cannabis. Medical treatment involves professional assessment, consideration of potential risks, appropriate prescribing, and ongoing monitoring.

Understanding Medical Cannabis in Australia

Australia has established a regulated framework for accessing medicinal cannabis. The Therapeutic Goods Administration (TGA) oversees the regulation of therapeutic goods and provides pathways through which eligible patients may access certain medicinal cannabis products.

Most medicinal cannabis products are not included in the Australian Register of Therapeutic Goods (ARTG). However, eligible products may be accessed through approved regulatory pathways, including the Special Access Scheme (SAS) and Authorised Prescriber (AP) scheme.

A medical practitioner must assess whether medicinal cannabis is appropriate for a patient's circumstances. This assessment may include reviewing medical history, previous treatments, current medications, symptoms, and potential contraindications.

Patients should understand that medicinal cannabis is not suitable for everyone. Its use requires an individualised medical assessment rather than a general recommendation.

Potential Applications of Cannabis-Based Medicines

Medical cannabis is being studied and used in selected clinical situations. However, the available scientific evidence differs depending on the condition, cannabinoid, formulation, and treatment approach.

Some areas where medicinal cannabis may be considered by healthcare professionals include:

1. Chronic Pain Management

Chronic pain can affect mobility, sleep, emotional wellbeing, and everyday activities. Some cannabinoid medicines have demonstrated modest benefits for certain types of neuropathic pain.

Medical cannabis may sometimes be considered as an additional treatment when conventional options have not provided sufficient relief or are unsuitable. However, evidence remains limited for several common pain conditions, including arthritis and musculoskeletal pain.

2. Epilepsy Management

Certain CBD-based prescription medicines have been studied for specific forms of severe epilepsy. Evidence supports the use of particular pharmaceutical CBD products for selected epilepsy syndromes.

This does not mean that all CBD products provide the same results. Treatment decisions should be made by an appropriately qualified medical practitioner, particularly when managing epilepsy or adjusting existing medication.

3. Multiple Sclerosis Symptoms

Some cannabis-based medicines have been investigated for symptoms associated with multiple sclerosis, particularly muscle spasticity.

Certain products may help selected patients manage specific symptoms, although individual responses vary. Medical supervision is important to assess potential benefits and monitor unwanted effects.

4. Chemotherapy-Related Nausea and Vomiting

Some THC-containing medicines have been studied for managing nausea and vomiting associated with chemotherapy. They may be considered in selected circumstances when conventional anti-nausea treatments have not been sufficiently effective.

However, modern antiemetic medicines are generally preferred as initial treatment options.

5. Palliative Care

In palliative care, the primary objective is to improve comfort and quality of life for people living with serious illnesses.

Cannabinoid medicines may be considered in selected situations for symptom management, depending on the patient's condition, existing medications, treatment goals, and clinical assessment.

It is important to understand that medicinal cannabis is not a proven cure for cancer or other serious diseases.

Understanding the Different Medical Cannabis Products

Cannabis-based medicines are available in different formulations, allowing healthcare professionals to consider individual treatment requirements.

Common formulations include:

•          CBD oils: Liquid preparations containing cannabidiol in measured concentrations.
•          THC oils: Liquid products containing tetrahydrocannabinol in prescribed strengths.
•          Balanced cannabinoid oils: Formulations containing both CBD and THC.
•          Capsules: Oral formulations designed to provide measured quantities of cannabinoids.
•          Oral sprays: Products administered into the mouth using a measured spray.
•          Dried cannabis products: Prescribed preparations supplied for specific medically supervised administration methods.

The appropriate formulation depends on the patient's medical history, treatment objectives, potential side effects, and prescribing considerations.

Patients should never substitute unregulated cannabis products for prescribed medicines without consulting their healthcare professional.

How to Access Cannabis-Based Treatment in Australia

Accessing medical cannabis in Australia involves a regulated medical process. Patients cannot independently apply to the TGA for approval to access unapproved medicinal cannabis products.

The process generally involves the following steps:

Step 1: Initial Medical Consultation

The patient discusses their symptoms, medical history, current health concerns, and previous treatments with a registered healthcare practitioner.

Step 2: Clinical Assessment

The practitioner evaluates whether medicinal cannabis may be clinically appropriate. This includes reviewing existing medications, possible contraindications, and alternative treatment options.

Step 3: Considering Regulatory Requirements

If an unapproved medicinal cannabis product is considered appropriate, the practitioner may need to obtain access through the TGA's Special Access Scheme or Authorised Prescriber scheme, depending on the circumstances.

Step 4: Prescription and Dispensing

Once the relevant requirements have been met, the prescribed product can be arranged through an appropriate pharmacy.

Step 5: Ongoing Monitoring

Patients may require follow-up consultations to review treatment response, side effects, and whether continuing treatment remains appropriate.

The TGA provides detailed information about these access pathways and their requirements.

Safety Considerations and Possible Side Effects

Although medicinal cannabis may be appropriate for selected patients, it is not free from risks. Understanding potential side effects is an important part of responsible treatment.

Possible adverse effects include:

•          Drowsiness and fatigue.
•          Dizziness and light-headedness.
•          Dry mouth.
•          Changes in appetite.
•          Impaired concentration and memory.
•          Anxiety or changes in mood.
•          Coordination and balance difficulties.
•          Potential interactions with other medications.

THC-containing products can cause intoxication and impair judgement, reaction time, and coordination. Higher THC exposure may also increase the risk of dependence and other psychological adverse effects.

Patients should inform their healthcare professional about all prescription medicines, over-the-counter products, and supplements they use.

Medicinal cannabis may not be suitable during pregnancy or breastfeeding, and particular caution is necessary for young people and individuals with certain mental health conditions.

Patients using THC-containing medicines should not drive or operate machinery while impaired. Australian driving laws vary by state and territory, and a medical prescription does not automatically provide a defence against drug-driving offences.

Professional guidance and regular monitoring are essential for reducing potential treatment risks.

Why Is Professional Medical Guidance Important?

Choosing a suitable treatment requires more than understanding the potential benefits of medicinal cannabis. Every patient has different medical needs, treatment histories, and health considerations.

A qualified healthcare professional can help patients understand:

1.     Whether cannabis-based treatment is appropriate for their circumstances.
2.     Which cannabinoid formulation may be considered.
3.     Potential benefits and limitations of the treatment.
4.     Possible interactions with existing medications.
5.     Appropriate monitoring and follow-up requirements.
6.    Alternative treatment options that may be available.

Patients should also understand that most medicinal cannabis products available in Australia are unapproved therapeutic goods. These products have not undergone the TGA's full assessment for safety, quality, and effectiveness before being made available through the relevant access pathways.

The Importance of Patient-Centred Care

Effective healthcare begins with understanding individual patient needs. Cannabis-based treatment should be considered as part of a broader healthcare plan rather than an isolated solution.

Patient-centred care involves open communication between patients and healthcare professionals. Patients should feel comfortable discussing their symptoms, previous treatment experiences, concerns, and expectations.

Regular consultations allow practitioners to evaluate whether a treatment is providing meaningful benefits and whether any adjustments are necessary.

It is equally important to establish realistic expectations. Medicinal cannabis does not work in the same way for everyone, and some patients may experience limited benefits or unwanted side effects.

An informed approach helps patients participate actively in decisions about their healthcare.

Choosing a Medical Cannabis Clinic in Australia

Finding an appropriate healthcare provider is an important step for individuals considering cannabis-based treatment in Australia.

When researching a medical cannabis clinic, consider the following factors:

•          Qualified Healthcare Professionals: Ensure consultations and prescribing decisions involve appropriately registered healthcare practitioners.
•          Individual Medical Assessments: Treatment recommendations should be based on personal medical history and clinical requirements.
•          Transparent Information: Patients should receive clear explanations about treatment options, potential risks, and costs.
•          Regulatory Compliance: The clinic and prescribing practitioners should follow applicable Australian medicinal cannabis regulations.
•          Ongoing Patient Support: Follow-up consultations should be available to monitor treatment progress and address concerns.
•          Responsible Prescribing: Medical decisions should prioritise patient safety and evidence-based healthcare practices.

A reliable healthcare provider should never guarantee treatment outcomes or suggest that medicinal cannabis is suitable for every medical condition.

Exploring Cannabis-Based Healthcare with Zenith Clinic

Access to reliable healthcare information can help patients better understand emerging treatment options and make informed decisions about their wellbeing.

Individuals interested in exploring medicinal cannabis can visit Zenith Clinic to learn more about its healthcare services and available information.

Before considering any cannabis-based medicine, patients should seek appropriate medical advice, discuss their treatment history, and understand the potential benefits and limitations.

Professional guidance, informed decision-making, and ongoing medical supervision remain essential elements of responsible healthcare.

Conclusion

Cannabis-based treatment in Australia is an evolving area of healthcare that continues to attract attention from patients, medical professionals, and researchers. Cannabinoids such as CBD and THC have been investigated for selected medical applications, including certain types of chronic pain, epilepsy, multiple sclerosis symptoms, and chemotherapy-related nausea.

However, medicinal cannabis is not a first-line treatment for any health condition in Australia, and the strength of scientific evidence varies considerably between applications.

Understanding the regulatory framework, available formulations, potential side effects, and individual treatment requirements is essential before considering medicinal cannabis.

With appropriate medical assessment and ongoing professional supervision, eligible patients can explore whether cannabis-based treatment is a suitable option within their broader healthcare plan.